Terms: = Liver cancer AND ARID2, ENSG00000189079, 196528, Q68CP9, p200, KIAA1557, FLJ30619, DKFZp779P0222, DKFZp686G052, BAF200
37 results:
1. Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts.
Yoshuantari N; Jeng YM; Liau JY; Lee CH; Tsai JH
Mod Pathol; 2023 Jan; 36(1):100042. PubMed ID: 36788061
[TBL] [Abstract] [Full Text] [Related]
2. Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.
Shi DM; Dong SS; Zhou HX; Song DQ; Wan JL; Wu WZ
Cell Signal; 2023 Apr; 104():110565. PubMed ID: 36539000
[TBL] [Abstract] [Full Text] [Related]
3. miR-29a-5p regulates the malignant biological process of liver cancer cells through arid2 regulation of EMT.
Li W; Jiang Y; Pan Q; Yang G
Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
[TBL] [Abstract] [Full Text] [Related]
4. Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma.
Lee HW; Kim E; Cho KJ; Park HJ; Seo J; Lee H; Baek E; Choi JR; Han KH; Lee ST; Park JY
Liver Int; 2022 Oct; 42(10):2317-2326. PubMed ID: 35776657
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma.
Sun J; Cheng NS
J Immunol Res; 2022; 2022():1688460. PubMed ID: 35402625
[TBL] [Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Kakuda Y; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
Cancer Med; 2022 Apr; 11(8):1769-1786. PubMed ID: 35174643
[TBL] [Abstract] [Full Text] [Related]
7. BRD4 inhibition induces synthetic lethality in arid2-deficient hepatocellular carcinoma by increasing DNA damage.
He DD; Shang XY; Wang N; Wang GX; He KY; Wang L; Han ZG
Oncogene; 2022 Mar; 41(10):1397-1409. PubMed ID: 35017665
[TBL] [Abstract] [Full Text] [Related]
8. Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection.
Tsai JH; Liau JY; Lee CH; Jeng YM
Am J Surg Pathol; 2021 Oct; 45(10):1409-1418. PubMed ID: 33859071
[TBL] [Abstract] [Full Text] [Related]
9.
Liu X; Zhang H; Zhou P; Yu Y; Zhang H; Chen L; Gong J; Liu Z
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786634
[TBL] [Abstract] [Full Text] [Related]
10. Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma.
Xu S; Guo Y; Zeng Y; Song Z; Zhu X; Fan N; Zhang Z; Ren G; Zang Y; Rao W
BMC Cancer; 2021 Feb; 21(1):152. PubMed ID: 33579226
[TBL] [Abstract] [Full Text] [Related]
11. Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
von Felden J; Craig AJ; Garcia-Lezana T; Labgaa I; Haber PK; D'Avola D; Asgharpour A; Dieterich D; Bonaccorso A; Torres-Martin M; Sia D; Sung MW; Tabrizian P; Schwartz M; Llovet JM; Villanueva A
Oncogene; 2021 Jan; 40(1):140-151. PubMed ID: 33097857
[TBL] [Abstract] [Full Text] [Related]
12. arid2 Chromatin Remodeler in Hepatocellular Carcinoma.
Loesch R; Chenane L; Colnot S
Cells; 2020 Sep; 9(10):. PubMed ID: 32977645
[TBL] [Abstract] [Full Text] [Related]
13. Targeted-gene sequencing of an undifferentiated gallbladder carcinoma: a case report.
Xiao Y; Xiang C; Yang D; Zhao B; Li Y; Yin H
Diagn Pathol; 2020 Jun; 15(1):66. PubMed ID: 32487254
[TBL] [Abstract] [Full Text] [Related]
14. Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations.
Fujita M; Yamaguchi R; Hasegawa T; Shimada S; Arihiro K; Hayashi S; Maejima K; Nakano K; Fujimoto A; Ono A; Aikata H; Ueno M; Hayami S; Tanaka H; Miyano S; Yamaue H; Chayama K; Kakimi K; Tanaka S; Imoto S; Nakagawa H
EBioMedicine; 2020 Mar; 53():102659. PubMed ID: 32113157
[TBL] [Abstract] [Full Text] [Related]
15. Chromatin remodeling factor arid2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
Jiang H; Cao HJ; Ma N; Bao WD; Wang JJ; Chen TW; Zhang EB; Yuan YM; Ni QZ; Zhang FK; Ding XF; Zheng QW; Wang YK; Zhu M; Wang X; Feng J; Zhang XL; Cheng SQ; Ma DJ; Qiu L; Li JJ; Xie D
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4770-4780. PubMed ID: 32071245
[TBL] [Abstract] [Full Text] [Related]
16. Multi-omic molecular comparison of primary versus metastatic pancreatic tumours.
Brar G; Blais EM; Joseph Bender R; Brody JR; Sohal D; Madhavan S; Picozzi VJ; Hendifar AE; Chung VM; Halverson D; Mikhail S; Matrisian LM; Rahib L; Petricoin E; Pishvaian MJ
Br J Cancer; 2019 Jul; 121(3):264-270. PubMed ID: 31292535
[TBL] [Abstract] [Full Text] [Related]
17. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
Howell J; Atkinson SR; Pinato DJ; Knapp S; Ward C; Minisini R; Burlone ME; Leutner M; Pirisi M; Büttner R; Khan SA; Thursz M; Odenthal M; Sharma R
Eur J Cancer; 2019 Jul; 116():56-66. PubMed ID: 31173963
[TBL] [Abstract] [Full Text] [Related]
18. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
[TBL] [Abstract] [Full Text] [Related]
19. Cholangiolocellular Carcinoma With "Ductal Plate Malformation" Pattern May Be Characterized by ARID1A Genetic Alterations.
Sasaki M; Sato Y; Nakanuma Y
Am J Surg Pathol; 2019 Mar; 43(3):352-360. PubMed ID: 30520820
[TBL] [Abstract] [Full Text] [Related]
20. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.
Chaisaingmongkol J; Budhu A; Dang H; Rabibhadana S; Pupacdi B; Kwon SM; Forgues M; Pomyen Y; Bhudhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Sricharunrat T; Phornphutkul K; Sangrajrang S; Cam M; He P; Hewitt SM; Ylaya K; Wu X; Andersen JB; Thorgeirsson SS; Waterfall JJ; Zhu YJ; Walling J; Stevenson HS; Edelman D; Meltzer PS; Loffredo CA; Hama N; Shibata T; Wiltrout RH; Harris CC; Mahidol C; Ruchirawat M; Wang XW;
Cancer Cell; 2017 Jul; 32(1):57-70.e3. PubMed ID: 28648284
[TBL] [Abstract] [Full Text] [Related]
[Next]